Cardio Diagnostics Holdings, Inc. (CDIOW) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
311 W. SUPERIOR STREET CHICAGO, IL 60645 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 1,283,523 | 4,117,521 | 526,625 | |||
| Cash and cash equivalent | 1,283,523 | 4,117,521 | 526,625 | |||
| Receivables | 4,960 | |||||
| Prepaid expense | 280,057 | |||||
| Deferred costs | (3,182) | |||||
| Other undisclosed current assets | 1,480,379 | 1,768,366 | ||||
| Total current assets: | 2,765,680 | 5,885,887 | 806,682 | |||
| Noncurrent Assets | ||||||
| Operating lease, right-of-use asset | 575,227 | |||||
| Property, plant and equipment | 571,873 | |||||
| Intangible assets, net (including goodwill) | 536,735 | 358,641 | ||||
| Intangible assets, net (excluding goodwill) | 536,735 | 358,641 | ||||
| Deposits noncurrent assets | 12,850 | 4,950 | ||||
| Other undisclosed noncurrent assets | 65,000,484 | |||||
| Total noncurrent assets: | 1,696,685 | 363,591 | 65,000,484 | |||
| TOTAL ASSETS: | 4,462,365 | 6,249,478 | 65,807,166 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 243,213 | 1,098,738 | 124,434 | |||
| Taxes payable | ✕ | ✕ | ✕ | 124,434 | ||
| Other undisclosed accounts payable and accrued liabilities | 243,213 | 1,098,738 | ||||
| Other undisclosed current liabilities | 597,929 | |||||
| Total current liabilities: | 841,142 | 1,098,738 | 124,434 | |||
| Noncurrent Liabilities | ||||||
| Liabilities, other than long-term debt | 663,099 | |||||
| Operating lease, liability | 663,099 | |||||
| Total noncurrent liabilities: | 663,099 | |||||
| Other undisclosed liabilities | 849,032 | |||||
| Total liabilities: | 1,504,241 | 1,947,770 | 124,434 | |||
| Temporary equity, including noncontrolling interest | 65,000,000 | |||||
| Equity | ||||||
| Equity, attributable to parent | 2,958,124 | 4,301,708 | 682,732 | |||
| Common stock | 205 | 95 | 16 | |||
| Additional paid in capital | 17,326,299 | 10,293,159 | 827,553 | |||
| Accumulated deficit | (14,368,380) | (5,991,546) | (144,837) | |||
| Total equity: | 2,958,124 | 4,301,708 | 682,732 | |||
| TOTAL LIABILITIES AND EQUITY: | 4,462,365 | 6,249,478 | 65,807,166 | |||
Income Statement (P&L) (USD)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
| Revenues | 17,065 | 950 | |||
| Gross profit: | 17,065 | 950 | |||
| Operating expenses | (7,259,524) | (4,549,401) | |||
| Operating loss: | (7,242,459) | (4,548,451) | |||
| Nonoperating expense (Other Nonoperating expense) | (1,134,375) | ||||
| Interest and debt expense | 193,350 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (8,183,484) | (4,548,451) | |||
| Other undisclosed loss from continuing operations before income taxes | (193,350) | (112,534) | |||
| Net loss attributable to parent: | (8,376,834) | (4,660,985) | |||
| Other undisclosed net income available to common stockholders, basic | 9,321,970 | ||||
| Net income (loss) available to common stockholders, diluted: | (8,376,834) | 4,660,985 | |||
Comprehensive Income (USD)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
| Net loss: | (8,376,834) | (4,660,985) | |||
| Comprehensive loss, net of tax, attributable to parent: | (8,376,834) | (4,660,985) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.